av/pacira-pharmaceuticals--big.svg

NASDAQ:PCRX

Pacira BioSciences, Inc.

  • Stock

USD

Last Close

29.65

09/05 20:00

Market Cap

1.49B

Beta: 0.76

Volume Today

2.30M

Avg: 596.19K

PE Ratio

207.02

PFCF: 11.04

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-63.91M
-
-13.72M
78.54%
1.86M
113.53%
-37.95M
2,144.67%
-42.61M
12.28%
-471K
98.89%
-11.02M
2,238.85%
145.52M
1,421.01%
41.98M
71.15%
15.91M
62.10%
41.95M
163.72%
depreciation and amortization
5.75M
-
10.04M
74.61%
11.47M
14.35%
12.92M
12.58%
13.83M
7.07%
13.16M
4.83%
19.58M
48.70%
19.91M
1.70%
28.55M
43.40%
91.50M
220.52%
75.57M
17.41%
deferred income tax
3.43M
-
158K
95.39%
58K
63.29%
389K
570.69%
5.87M
1,407.71%
919K
84.33%
5.33M
479.43%
-126.61M
2,477.71%
10.87M
108.59%
-7.95M
173.08%
15.62M
296.54%
stock based compensation
11.51M
-
24.82M
115.60%
33.37M
34.43%
31.25M
6.35%
31.60M
1.13%
31.73M
0.39%
33.65M
6.07%
39.92M
18.63%
42.25M
5.83%
48.09M
13.84%
47.90M
0.41%
change in working capital
-4.42M
-
-456K
89.67%
-22.34M
4,800%
22.28M
199.71%
-2.57M
111.55%
-10.86M
321.79%
-8.77M
19.22%
-24.39M
178.06%
-18.67M
23.42%
-16.43M
12.00%
-45.78M
178.57%
accounts receivables
-10.24M
-
-7.78M
24.05%
-3.49M
55.13%
-4.08M
17.00%
-1.72M
57.84%
-6.00M
248.58%
-8.52M
42.09%
-5.52M
35.29%
-10.43M
89.16%
-2.08M
80.07%
-7.16M
244.35%
inventory
-3.48M
-
-13.71M
293.85%
-32.38M
136.26%
30.37M
193.78%
-10.13M
133.37%
-7.16M
29.37%
-8.03M
12.14%
-6.35M
20.84%
-4.47M
29.69%
2.49M
155.65%
-8.29M
433.47%
accounts payables
10.24M
-
14.25M
39.14%
9.94M
30.26%
-2.58M
125.95%
12.84M
597.48%
-573K
104.46%
-1.82M
217.98%
-3.31M
81.78%
-10.26M
209.84%
6.27M
161.12%
916K
85.40%
other working capital
-941K
-
6.77M
819.66%
3.59M
47.05%
-1.43M
139.77%
-3.56M
149.30%
2.87M
180.79%
9.60M
234.33%
-9.21M
195.87%
6.49M
170.49%
-23.11M
456.17%
-31.24M
35.19%
other non cash items
4.42M
-
4.63M
4.71%
4.58M
0.93%
4.57M
0.35%
11.67M
155.55%
14.39M
23.29%
31.75M
120.69%
22.68M
28.58%
20.75M
8.53%
14.15M
31.79%
19.39M
37.01%
net cash provided by operating activities
-43.22M
-
25.47M
158.93%
29.00M
13.85%
33.45M
15.37%
17.79M
46.84%
48.87M
174.78%
70.52M
44.30%
77.03M
9.23%
125.72M
63.20%
145.27M
15.56%
154.65M
6.45%
investments in property plant and equipment
-12.79M
-
-21.89M
71.09%
-41.27M
88.54%
-24.71M
40.13%
-19.27M
22.03%
-14.51M
24.67%
-10.16M
30.01%
-37.80M
272.09%
-45.87M
21.34%
-30.08M
34.43%
-15.16M
49.59%
acquisitions net
-2M
-
-13M
550%
-7M
46.15%
-16M
128.57%
-15M
6.25%
-7M
53.33%
-119.31M
1,604.47%
-1.16M
99.03%
-437.23M
37,592.16%
purchases of investments
-114.30M
-
-164.30M
43.75%
-189.08M
15.08%
-192.81M
1.97%
-502.75M
160.74%
-363.25M
27.75%
-318.48M
12.32%
-546.52M
71.60%
-611.49M
11.89%
-400.69M
34.47%
-144.37M
63.97%
sales maturities of investments
85.56M
-
80.29M
6.17%
217.24M
170.58%
171.63M
21.00%
321.71M
87.45%
405.19M
25.95%
319.47M
21.16%
307.87M
3.63%
1.08B
250.08%
237.58M
77.96%
237.07M
0.21%
other investing activites
-31K
-
-433K
1,296.77%
-119K
72.52%
143K
220.17%
-8.46M
6,016.08%
157K
101.86%
-4M
-
-32M
700%
net cash used for investing activites
-43.56M
-
-119.34M
173.96%
-20.23M
83.05%
-61.75M
205.24%
-223.76M
262.35%
20.58M
109.20%
-128.49M
724.46%
-277.61M
116.06%
-20.79M
92.51%
-225.19M
983.14%
77.54M
134.43%
debt repayment
-27.50M
-
-118.19M
-
-338K
-
-209.88M
61,995.27%
-359.20M
71.15%
-427.69M
19.07%
-187.68M
56.12%
common stock issued
110.45M
-
3.93M
96.44%
120.96M
-
10.87M
-
47.76M
339.37%
26.66M
44.19%
24.39M
8.51%
4.75M
80.52%
common stock repurchased
-10.87M
-
-33.09M
204.38%
2.81M
108.50%
2.95M
5.09%
2.81M
4.84%
dividends paid
-4.32M
-
-1.62M
62.50%
-2.67M
65.20%
-2.81M
-
other financing activites
116.67M
-
8.42M
92.78%
6.77M
19.62%
7.26M
7.25%
221.40M
2,949.10%
8.95M
95.96%
8.32M
7.05%
419.13M
4,935.79%
713.11M
70.14%
-1.18M
100.16%
-106K
90.98%
net cash used provided by financing activities
89.17M
-
118.88M
33.32%
10.70M
91.00%
7.26M
32.13%
224.16M
2,987.21%
8.95M
96.01%
3.67M
59.01%
222.30M
5,957.33%
380.69M
71.25%
-401.53M
205.47%
-183.03M
54.42%
effect of forex changes on cash
105.49M
-
net change in cash
2.39M
-
25.00M
946.67%
19.46M
22.16%
-21.04M
208.10%
18.18M
186.42%
78.40M
331.20%
-54.30M
169.26%
21.73M
140.02%
485.62M
2,134.90%
-481.44M
199.14%
49.16M
110.21%
cash at beginning of period
10.13M
-
12.52M
23.59%
37.52M
199.80%
56.98M
51.88%
35.94M
36.92%
54.13M
50.58%
132.53M
144.85%
78.23M
40.97%
99.96M
27.78%
585.58M
485.83%
104.14M
82.22%
cash at end of period
12.52M
-
37.52M
199.80%
56.98M
51.88%
35.94M
36.92%
54.13M
50.58%
132.53M
144.85%
78.23M
40.97%
99.96M
27.78%
585.58M
485.83%
104.14M
82.22%
153.30M
47.21%
operating cash flow
-43.22M
-
25.47M
158.93%
29.00M
13.85%
33.45M
15.37%
17.79M
46.84%
48.87M
174.78%
70.52M
44.30%
77.03M
9.23%
125.72M
63.20%
145.27M
15.56%
154.65M
6.45%
capital expenditure
-12.79M
-
-21.89M
71.09%
-41.27M
88.54%
-24.71M
40.13%
-19.27M
22.03%
-14.51M
24.67%
-10.16M
30.01%
-37.80M
272.09%
-45.87M
21.34%
-30.08M
34.43%
-15.16M
49.59%
free cash flow
-56.01M
-
3.58M
106.39%
-12.27M
442.85%
8.74M
171.24%
-1.48M
116.94%
34.36M
2,419.78%
60.36M
75.69%
39.23M
35.01%
79.85M
103.54%
115.20M
44.27%
139.49M
21.09%

All numbers in USD (except ratios and percentages)